Norvasc Tablet
Product Images NDC 58151-354

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norvasc (NDC 58151-354). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine Besylate Structural Formula (Image 01)

Amlodipine Besylate Structural Formula (Image 01)
Chemical structure diagram of amlodipine besylate, the active ingredient in Norvasc. The diagram shows the molecular composition and arrangement of atoms for this compound.*
FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for NORVASC versus Placebo)

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for NORVASC versus Placebo)
A Kaplan-Meier plot illustrating the event rate over time in months for two groups labeled 'Placebo' and 'Amlodipine'. The graph includes statistical information such as p-value, hazard ratio, and 95% confidence interval. The x-axis represents time in months, and the y-axis shows the event rate. Numbers at risk are indicated below the time axis.*
FDA Label Image

Figure 2 – Effects On Primary Endpoint Of Norvasc Versus Placebo Across Sub-groups (Image 03)

Figure 2 – Effects On Primary Endpoint Of Norvasc Versus Placebo Across Sub-groups (Image 03)
A forest plot chart displaying hazard ratios with 95% confidence intervals for various subgroups of patients comparing amlodipine versus placebo. Subgroups include age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent status. The plot visually indicates which groups favor amlodipine or placebo based on hazard ratios around a reference line at 1.0.*
FDA Label Image

Norvasc 2.5 mg Bottle Label (Image 04)

Norvasc 2.5 mg Bottle Label (Image 04)
Norvasc 2.5 mg tablets packaging label showing the product name and strength prominently. It contains amlodipine besylate as the active ingredient and is distributed by Viatris Specialty LLC. The label indicates a quantity of 90 tablets, prescription use only, and storage instructions to keep at controlled room temperature (59° to 86°F). Viatris branding is also visible on the label.*
FDA Label Image

Norvasc 5 mg Bottle Label (Image 05)

Norvasc 5 mg Bottle Label (Image 05)
Norvasc 5 mg tablets label with amlodipine besylate as the active ingredient. The label indicates a package size of 90 tablets, prescription use only, and is distributed by Viatris Specialty LLC. Storage instructions specify controlled room temperature and protection from light. The label includes NDC 58151-354-77 and Viatris branding.*
FDA Label Image

Norvasc 10 mg Bottle Label (Image 08)

Norvasc 10 mg Bottle Label (Image 08)
Norvasc 10 mg tablets label showing the brand name, generic name amlodipine besylate, and strength 10 mg. The label indicates a package size of 90 tablets, prescription only status, and is distributed by Viatris Specialty LLC. Storage instructions and other regulatory markings are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.